In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading
Avastin Improves Outcomes for Women with Advanced Cervical Cancer (June 10, 2013)In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading
Following Lifestyle Recommendations Reduces Risk of Cancer Death (May 15, 2013)People who follow the diet and lifestyle recommendations laid out by the World Cancer Research Fund (WCRF) and the American Institute for Cancer Research (AICR) have a 34 percent reduced risk of dying from several diseases and specifically, a 20 percent... Continue Reading
HPV Test Appropriate After Indeterminate Pap Test (April 29, 2013)Women who have an indeterminate Pap smear should undergo human papillomavirus (HPV) testing rather than another Pap smear, according to the results of Cochrane Review. Cancer screening refers to the use of tests to detect cancer in individuals who do... Continue Reading
Cancer Deaths on the Decline (February 11, 2013)Overall cancer death rates continue to decline in both men and women and across major ethnic and racial groups, according to the annual Status of Cancer report published in the Journal of the National Cancer Institute. What’s more—cancer incidence... Continue Reading
Gardasil is Safe, According to Large Study (October 12, 2012)The HPV vaccine Gardasil® (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) was found to be safe, according to the results of a large safety study published in the Archives of Pediatrics & Adolescent Medicine. The study... Continue Reading
HPV Testing Can Predict Risk of Cervical Cancer for Up to 18 Years (August 8, 2012)A test for the human papillomavirus (HPV) provides information about a woman’s long-term risk of cervical precancers, according to the results of a study published early online in the Journal of Clinical Oncology. Each year in the United States, there... Continue Reading
Approximately 16% of Worldwide Cancers Caused By Preventable Infections (May 17, 2012)Two million cancer cases each year—or roughly 16 percent of cancers worldwide—are the result of preventable and treatable infections such as human papillomavirus (HPV) and Hepatitis C (HCV), according to the results of a study published in The Lancet... Continue Reading
Aspirin Continues to Look Promising for Cancer Prevention (March 26, 2012)A combined analysis of 51 randomized trials found that daily aspirin use reduces the risk of new cancer diagnoses as well as the risk of cancer death. These results were published in The Lancet. A growing body of evidence suggests that aspirin may reduce... Continue Reading
Cervical Cancer Screening Guidelines Updated (March 21, 2012)According to updated recommendations from the US Preventive Services Task Force, options for cervical cancer screening include a Pap test every three years for women between the ages of 21 and 65, or—for women between the ages of 30 and 65—a Pap test... Continue Reading
In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading
Avastin Improves Outcomes for Women with Advanced Cervical Cancer (June 10, 2013)In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading
January Is National Cervical Cancer Awareness Month (March 8, 2009)January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading
Updates in the Management of Gynecologic Cancers (May 27, 2008)Updates in the Management of Gynecologic Cancers: A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists The 39th Annual Meeting of the Society of Gynecologic Oncologists (SGO) was held in Tampa, Florida, from March 9 to 12, 2008,... Continue Reading
More Metastatic/Stage IVB Cervical CancerIn a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading
Avastin Improves Outcomes for Women with Advanced Cervical Cancer (June 10, 2013)In a Phase III clinical trial, adding Avastin® (bevacizumab) to chemotherapy prolonged overall survival among women with recurrent or metastatic cervical cancer. These results were presented at the 2013 Annual Meeting of the American Society of Clinical... Continue Reading
Study Evaluates Whole-brain Radiation Following Surgery or Radiosurgery in Cancer Spread to the Brain (November 16, 2010)Results from a randomized Phase III study indicate that whole-brain radiation therapy (WBRT) following removal of one to three brain metastases with surgery or radiosurgery does not improve overall survival or duration of functional independence but does... Continue Reading
Avastin® Shows Promise in Treatment of Cervical Cancer (March 8, 2009)Avastin® Shows Promise in Treatment of Cervical Cancer According to the results of a Phase II clinical trial, the targeted therapy Avastin® (bevacizumab) warrants further investigation in the treatment of persistent or recurrent squamous cell carcinoma... Continue Reading
January Is National Cervical Cancer Awareness Month (March 8, 2009)January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading
More Recurrent Cervical CancerWomen who have an indeterminate Pap smear should undergo human papillomavirus (HPV) testing rather than another Pap smear, according to the results of Cochrane Review. Cancer screening refers to the use of tests to detect cancer in individuals who do... Continue Reading
HPV Vaccination Does Not Lead to Increase in Sex (October 19, 2012)Vaccination against the human papillomavirus (HPV) does not lead to increased sexual activity, according to the results of a study published in the journal Vaccine. HPV is the most common sexually transmitted infection in the United States. There are... Continue Reading
Gardasil is Safe, According to Large Study (October 12, 2012)The HPV vaccine Gardasil® (quadrivalent human papillomavirus [types 6, 11, 16, 18] recombinant vaccine) was found to be safe, according to the results of a large safety study published in the Archives of Pediatrics & Adolescent Medicine. The study... Continue Reading
HPV Testing Can Predict Risk of Cervical Cancer for Up to 18 Years (August 8, 2012)A test for the human papillomavirus (HPV) provides information about a woman’s long-term risk of cervical precancers, according to the results of a study published early online in the Journal of Clinical Oncology. Each year in the United States, there... Continue Reading
HPV Vaccine Reducing Infection among Vaccinated and Unvaccinated (July 16, 2012)The human papillomavirus (HPV) vaccine is reducing infections of virus strains associated with genital warts and cancer, even among those who remain unvaccinated, according to the results of a study published in Pediatrics. HPV is the most common sexually... Continue Reading
More Screening/Prevention Cervical CancerSentinel Node Biopsy Is a Minimally-invasive, Effective Method for Determining Spread of Cervical Cancer The majority of women with cervical cancer can safely undergo sentinel node biopsy instead of full pelvic lymph node dissection to determine the spread... Continue Reading
January Is National Cervical Cancer Awareness Month (March 8, 2009)January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading
Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer (March 8, 2009)Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer Robotically-assisted hysterectomy (RAH) in patients with early-stage cervical cancer is at least as effective as traditional open radical hysterectomy (ORH) and produces fewer complications,... Continue Reading
Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (March 8, 2009)Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison... Continue Reading
Updates in the Management of Gynecologic Cancers (May 27, 2008)Updates in the Management of Gynecologic Cancers: A Report from the 39th Annual Meeting of the Society of Gynecologic Oncologists The 39th Annual Meeting of the Society of Gynecologic Oncologists (SGO) was held in Tampa, Florida, from March 9 to 12, 2008,... Continue Reading
More Stage I Cervical CancerA systematic review of 47 studies evaluating treatment for melanoma, head and neck cancer, genitourinary cancers, gynecologic cancers, and sarcoma indicates that lymphedema is a common side effect of treatment for these diseases. These findings were recently... Continue Reading
Gemzar® Added to Chemoradiation Improves Survival in Locally Advanced Cervical Cancer (June 8, 2009)Gemzar® Added to Chemoradiation Improves Survival in Locally Advanced Cervical Cancer The combination of Gemzar® (gemcitabine), Platinol® (cisplatin), and concurrent radiation significantly improves survival over single-agent Platinol and radiation... Continue Reading
January Is National Cervical Cancer Awareness Month (March 8, 2009)January Is National Cervical Cancer Awareness Month As the month of January brings cervical cancer into focus, it’s a great time to increase public understanding of the disease, including its prevalence, approaches to screening and prevention, treatment... Continue Reading
Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer (March 8, 2009)Robotically-assisted Hysterectomy Appears Effective for Cervical Cancer Robotically-assisted hysterectomy (RAH) in patients with early-stage cervical cancer is at least as effective as traditional open radical hysterectomy (ORH) and produces fewer complications,... Continue Reading
Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers (March 8, 2009)Differences in IMRT Radiation Doses May Complicate Study Results in Gynecological Cancers Differences between the prescribed dose of radiation in intensity modulated radiation therapy (IMRT) and the dose that’s actually delivered may make comparison... Continue Reading
More Stages II-IVA Cervical Cancer